Ausgabe 3/2014
Inhalt (14 Artikel)
Predictors of Genetic Testing Decisions: A Systematic Review and Critique of the Literature
Kate Sweeny, Arezou Ghane, Angela M. Legg, Ho Phi Huynh, Sara E. Andrews
Diagnostic Exome Sequencing Identifies Two Novel IQSEC2 Mutations Associated with X-Linked Intellectual Disability with Seizures: Implications for Genetic Counseling and Clinical Diagnosis
Stephanie K. Gandomi, K. D. Farwell Gonzalez, M. Parra, L. Shahmirzadi, J. Mancuso, P. Pichurin, R. Temme, S. Dugan, W. Zeng, Sha Tang
Classifying Married Adults Diagnosed With Alpha-1 Antitrypsin Deficiency Based on Spousal Communication Patterns Using Latent Class Analysis: Insights for Intervention
Rachel A. Smith, Sara E. Wienke, Michelle K. Baker
African American Women’s Limited Knowledge and Experiences with Genetic Counseling for Hereditary Breast Cancer
Vanessa B. Sheppard, Kristi D. Graves, Juleen Christopher, Alejandra Hurtado-de-Mendoza, Costellia Talley, Karen Patricia Williams
The Value of a Genetic Counselor: Improving Identification of Cancer Genetic Counseling Patients with Chart Review
Jennifer N. Eichmeyer, Christa Burnham, Patty Sproat, Rick Tivis, Thomas M. Beck
MPS II: Adaptive Behavior of Patients and Impact on the Family System
Mary Needham, Wendy Packman, Maxwell Rappoport, Natasha Quinn, Matthew Cordova, Sandra Macias, Cynthia Morgan, Seymour Packman
An Exploration of the Experience of Huntington’s Disease in Family Dyads: An Interpretative Phenomenological Analysis
Caroline Maxted, Jane Simpson, Stephen Weatherhead
Seeking Balance: Decision Support Needs of Women Without Cancer and a Deleterious BRCA1 or BRCA2 Mutation
Meghan L. Underhill, Cheryl B. Crotser
Looking Back and Moving Forward: An Historical Perspective from Laboratory Genetic Counselors
Lindsay H. Zetzsche, Katrina E. Kotzer, Karen E. Wain
Prevalence of the HOXB13 G84E Mutation Among Unaffected Men with a Family History of Prostate Cancer
Elizabeth Handorf, Nicole Crumpler, Laura Gross, Veda N. Giri
Genetic Counselors’ Experience with Cell-Free Fetal DNA Testing as a Prenatal Screening Option for Aneuploidy
Julie M. H. Horsting, Stephen R. Dlouhy, Katelyn Hanson, Kimberly Quaid, Shaochun Bai, Karrie A. Hines
Public Trust in Genomic Risk Assessment for Type 2 Diabetes Mellitus
Rachel Mills, William Barry, Susanne B. Haga
Informing Children of Their Newborn Screening Carrier Result for Sickle Cell or Cystic Fibrosis: Qualitative Study of Parents’ Intentions, Views and Support Needs
Fiona Ulph, Tim Cullinan, Nadeem Qureshi, Joe Kai
Perceived Risk Following Melanoma Genetic Testing: A 2-Year Prospective Study Distinguishing Subjective Estimates from Recall
Lisa G. Aspinwall, Jennifer M. Taber, Wendy Kohlmann, Samantha L. Leaf, Sancy A. Leachman